Picton Mahoney Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$40.6M 1301
2025
Q4
$40.6M Buy
+400,000
New +$32.1M 0.31% 59
2021
Q4
Sell
-27,665
Closed -$2.64M 976
2021
Q3
$2.64M Hold
27,665
0.1% 256
2021
Q2
$3.44M Buy
27,665
+6,022
+28% +$719K 0.1% 171
2021
Q1
$2.85M Sell
21,643
-13,008
-38% -$1.78M 0.14% 239
2020
Q4
$4.59M Buy
34,651
+3,346
+11% +$405K 0.22% 127
2020
Q3
$3.19M Buy
+31,305
New +$2.7M 0.18% 151

Other funds holding EXAS

Picton Mahoney Asset Management's EXAS Position: Q1 2026 in Review

Picton Mahoney Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 400,000 shares — an estimated $40.6M sold.

Picton Mahoney Asset Management first reported a position in EXAS in Q3 2020 and held it in 6 quarters. The position peaked at $40.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Picton Mahoney Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 400,000 Exact Sciences shares in Q1 2026, an estimated $40.6M.
  • Picton Mahoney Asset Management first reported a position in Exact Sciences in Q3 2020 and held it in 6 quarters.
  • Picton Mahoney Asset Management's Exact Sciences position peaked at $40.6M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.